BOMBAY STOCK EXCHANGE

Bombay Stock Exchange's benchmark Sensex fell Tuesday by more than 145 points, or 1 percent, as the rupee tumbled to a record low of 55.39 against the dollar.

The Indian rupee Monday touched a record low of 55 against the dollar because of the strong demand for dollar from importers, weak global cues and delay over policy reforms from the government.

Bombay Stock Exchange's Sensex lost more than 100 points Monday afternoon trade as the slump in European markets and a worse-than-expected inflation for April hit the markets hard.

Bombay Stock Exchange (BSE) sensex closed at a four month low by shedding nearly 67 points on Wednesday as weak global trends triggered heavy fund outflows.The BSE bench mark 30 share index lost 66.60 points to reach 16,479.59, dragged down by sharp declines in Reliance industry and banking stocks. Reliance Industries dropped for the sixth day by losing 1.91 per cent to Rs 695.10 after it cut the estimates for actual natural gas reserves available in its Indian blocks.

Indian stock markets gained Friday as shares of ICICI Bank and Axis Bank rallied ahead on expectations of good quarter four earnings.

Indian software giant Tata Consultancy Services Ltd (TCS) shares gained 12.4 percent in Mumbai trading on Tuesday morning, piggybacking on the company's robust outlook and a 23 percent surge in fourth quarter profits.

Asian stock markets ended lower on Monday as manufacturing data from China failed to ease concerns over a slowdown in the world’s second biggest economy.

The BSE Sensex ended flat in a short special trading session on Saturday as investors remained cautious ahead of results of state elections due this week.

Everyone knows that industry consolidation leads to improved shareholder returns. India's mobile market may be the exception. Revocation of 2G licences and now a change in M&A rules are expected to force a long-awaited deal frenzy in this challenging sector.

The BSE Sensex snapped a six-session rally early on Monday as some investors booked profits after the main index rose more than 11 percent this month.

Indian Rupee gained Thursday, breaking an eight-session losing streak, after the country's central bank, Reserve Bank of India (RBI), took several measures to stem the fall of rupee against the greenback.

U.S. listed software company iGate said that it plans to delist shares of its unit Patni Computer Systems to obtain full ownership of the company.

Environment ministry has given state-run Steel Authority of India Ltd (SAIL) approval to mine iron ore at Chiria in Jharkhand, the ministry said in a statement on its website.

SKS Microfinance shares rose 13 percent on Thursday, a day after a panel appointed by the Reserve Bank submitted guidelines for the microfinance sector, providing clarity for the country's embattled industry.

India’s top software services company Tata Consultancy Services Ltd (TCS) on Tuesday announced plans to recruit 37,000 professionals in the next year through campus placements for its domestic and overseas operations.

Indian pharmaceutical company Strides Arcolab on Tuesday said it got the United States Food and Drug Administration (FDA) approval to sell an additional package size of Adenosine injection used for treating cardiac diseases.

India’s second biggest software services company Infosys Technologies Ltd on Thursday said its attrition rate for the October-December quarter has shot up on an annualized basis, but that it had added 5,311 employees to take its total headcount to 127,779.

India’s second biggest software services company Infosys Technologies Ltd reported a 14 percent rise in its third-quarter net profit missing analysts expectations, sending its shares down by more than 4 percent.

India’s Bombay Stock Exchange (BSE) has introduced a new stock index which comprises companies that satisfy the legal codes of Islam.

Indian equity markets are trading lower by 328.30 points or 1.59 percent on Friday with all sectoral indices are in the negative side.

Ranbaxy Laboratories Limited (RLL), India's largest pharmaceutical company, said on Thursday its consolidated net profit stood at 3.13 billion rupees ($67 million) for the third quarter ended September 30, 2010, as compared to 1.16 billion rupees ($24 million) in the same period a year earlier.